NRG1 and hydrops fetalis: Although the use of human-recombinant NRG-1 in HF patients significantly increased cardiac output and LVEF, its circulating expression and functional significance as a biomarker in the development of unfavorable post-MI remodeling in patients with STEMI are still unknown [217].